Atea Pharmaceuticals Inc.

NASDAQ: AVIR · Real-Time Price · USD
3.46
-0.03 (-0.86%)
At close: Aug 15, 2025, 1:15 PM

Atea Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for AVIR stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 73.41% from the current stock price of 3.46.

Target Low Average Median High
Price 6 6 6 6
Change 73.41% 73.41% 73.41% 73.41%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Atea Pharmaceuticals Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Apr 25
Strong Buy 0
Buy 0
Hold 1
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
7.08M
from 0
Increased by n/a%
Revenue Next Year
5.74M
from 7.08M
Increased by -18.9%
EPS This Year
-1.64
from -2
Increased by 18.0%
EPS Next Year
-1.65
from -1.64
Increased by -0.6%